
Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves
2018; Lippincott Williams & Wilkins; Volume: 137; Issue: 4 Linguagem: Inglês
10.1161/circulationaha.117.030729
ISSN1524-4539
AutoresDanny Dvir, Thierry Bourguignon, Catherine M Otto, Rebecca T. Hahn, Raphaël Rosenhek, John G. Webb, Hendrik Treede, Maurice Enriquez‐Sarano, Ted Feldman, Harindra C. Wijeysundera, Yan Topilsky, Michel Aupart, Michael J. Reardon, G. Burkhard Mackensen, Wilson Y. Szeto, Ran Kornowski, James S. Gammie, Ajit P. Yoganathan, Yaron Arbel, Michael A. Borger, Matheus Simonato, Mark Reisman, Raj Makkar, Alexandre Abizaid, James M. McCabe, Gry Dahle, Gabriel S. Aldea, Jonathon Leipsic, Philippe Pîbarot, Neil Moat, Michael J. Mack, A. Pieter Kappetein, Martin B. Leon,
Tópico(s)Aortic Disease and Treatment Approaches
ResumoBioprostheses are prone to structural valve degeneration, resulting in limited long-term durability. A significant challenge when comparing the durability of different types of bioprostheses is the lack of a standardized terminology for the definition of a degenerated valve. This issue becomes especially important when we try to compare the degeneration rate of surgically inserted and transcatheter bioprosthetic valves. This document, by the VIVID (Valve-in-Valve International Data), proposes practical and standardized definitions of valve degeneration and provides recommendations for the timing of clinical and imaging follow-up assessments accordingly. Its goal is to improve the quality of research and clinical care for patients with deteriorated bioprostheses by providing objective and strict criteria that can be utilized in future clinical trials. We hope that the adoption of these criteria by both the cardiological and surgical communities will lead to improved comparability and interpretation of durability analyses.
Referência(s)